← Eichor
Study identifier: NCT06744816 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Condition: Peripheral Neuropathy Due to Chemotherapy  ·  Sponsor: M.D. Anderson Cancer Center

PhaseEARLY_Phase 1
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To learn if topical capsaicin can help relieve pain from CIPN and improve gait (the pattern of walking) in patients.

This description comes directly from the study's public registry record.

Talk to the study team

Saba Javed, MD  ·  713-792-9530  ·  sjaved@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

MD Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06744816